Growth hormone (GH) research continues to be an active area of scientific interest, particularly in studies exploring metabolism, body composition, tissue repair signaling pathways, and endocrine regulation. Among the most commonly studied growth hormone–releasing hormone (GHRH) analogs are CJC-1295 with DAC and CJC-1295 without DAC (also known as Modified GRF 1-29).

While both compounds are structurally related and operate through similar receptor pathways, they behave very differently in research models. Understanding these differences is essential for laboratories evaluating dosing frequency, pharmacokinetics, and growth hormone pulsatility.

This article provides a detailed breakdown of CJC-1295 DAC vs. No DAC » , including mechanism of action, half-life differences, research implications, and practical considerations.

Restore Peptides

1209 Mountain PL NE STE R

Albuquerque, New Mexico

87110 USA

Email: support@restorepeptides.io »

Phone: +1 702-344-1822